Description
Milbemax Allwormer offers comprehensive protection for dogs against a wide range of gastrointestinal worms, including roundworm, hookworm, whipworm, and tapeworm. Monthly administration also protects against heartworm. These small, easy-to-administer tablets can be paired with flea treatments for full-spectrum protection against internal and external parasites.
Benefits & Features:
- Broad-spectrum worm control: Effective against roundworm, hookworm, whipworm, and tapeworm.
 - Heartworm prevention: Monthly dosage protects dogs from heartworm disease.
 - Compact and easy to administer: Small tablets for convenient dosing.
 - Compatible with flea treatments: Can be used alongside Credelio, Bravecto, or Simparica.
 
Directions for Use:
- Weigh your dog before treatment to determine the correct tablet size.
 - Administer orally as a single dose with or after food.
 - Dosage:
 - Small dog tablets: For dogs 0.5 kg to 5 kg.
 - Large dog tablets: For dogs 5 kg to 25 kg.
 - Puppies/tiny dogs (0.5–1 kg): ½ small dog tablet.
 - Dogs (25–50 kg): 2 large dog tablets.
 - Recommended Schedule:
 - Puppies: Every 2 weeks from 2–12 weeks old, then monthly from 3–6 months.
 - Adult dogs: Every 3 months.
 - Breeding bitches: Treat before mating, 10 days before whelping, and 2 and 4 weeks after whelping.
 
Cautions:
- Not for use in puppies under 2 weeks of age.
 - Consult a vet before use for Collie breeds or dogs with known sensitivity to ingredients.
 - Do not administer to dogs already infected with heartworm.
 
Possible Side Effects:
- Side effects are rare at recommended dosages.
 - Safe for puppies (from 2 weeks), senior pets, working dogs, greyhounds, and breeding dogs.
 - Can be combined with other treatments like flea/tick products and vaccinations.
 
Ingredients:
- Milbemycin: For roundworm and heartworm control.
 - Praziquantel: For effective tapeworm treatment.
 
Available Options:
- Tablet color: Light Blue (for dogs under 5 kg), Blue (for dogs over 5 kg).
 - Pack sizes: Available in packs of 2, or 4 tablets.
 
            
            
                                        